![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CXADR |
Gene summary for CXADR |
![]() |
Gene information | Species | Human | Gene symbol | CXADR | Gene ID | 1525 |
Gene name | CXADR Ig-like cell adhesion molecule | |
Gene Alias | CAR | |
Cytomap | 21q21.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P78310 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1525 | CXADR | GSM4909282 | Human | Breast | IDC | 1.14e-17 | 6.30e-01 | -0.0288 |
1525 | CXADR | GSM4909285 | Human | Breast | IDC | 3.05e-22 | 6.32e-01 | 0.21 |
1525 | CXADR | GSM4909291 | Human | Breast | IDC | 5.16e-05 | -2.57e-01 | 0.1753 |
1525 | CXADR | GSM4909293 | Human | Breast | IDC | 1.95e-03 | -2.03e-01 | 0.1581 |
1525 | CXADR | GSM4909296 | Human | Breast | IDC | 4.19e-11 | -2.21e-01 | 0.1524 |
1525 | CXADR | GSM4909297 | Human | Breast | IDC | 1.49e-04 | 1.10e-01 | 0.1517 |
1525 | CXADR | GSM4909301 | Human | Breast | IDC | 3.21e-04 | -1.67e-01 | 0.1577 |
1525 | CXADR | GSM4909306 | Human | Breast | IDC | 2.29e-02 | -1.86e-01 | 0.1564 |
1525 | CXADR | GSM4909311 | Human | Breast | IDC | 4.96e-14 | -2.18e-01 | 0.1534 |
1525 | CXADR | GSM4909312 | Human | Breast | IDC | 6.55e-03 | -3.75e-02 | 0.1552 |
1525 | CXADR | GSM4909319 | Human | Breast | IDC | 2.31e-15 | -2.69e-01 | 0.1563 |
1525 | CXADR | GSM4909320 | Human | Breast | IDC | 1.65e-03 | -2.39e-01 | 0.1575 |
1525 | CXADR | GSM4909321 | Human | Breast | IDC | 6.00e-08 | -1.54e-01 | 0.1559 |
1525 | CXADR | brca2 | Human | Breast | Precancer | 9.16e-06 | 3.75e-01 | -0.024 |
1525 | CXADR | brca3 | Human | Breast | Precancer | 3.54e-04 | 2.93e-01 | -0.0263 |
1525 | CXADR | M1 | Human | Breast | IDC | 1.45e-02 | -2.36e-01 | 0.1577 |
1525 | CXADR | NCCBC14 | Human | Breast | DCIS | 4.79e-04 | -1.21e-01 | 0.2021 |
1525 | CXADR | NCCBC5 | Human | Breast | DCIS | 1.71e-08 | -2.31e-01 | 0.2046 |
1525 | CXADR | P1 | Human | Breast | IDC | 2.40e-08 | -2.60e-01 | 0.1527 |
1525 | CXADR | DCIS2 | Human | Breast | DCIS | 3.56e-37 | 1.04e-01 | 0.0085 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004440922 | Liver | Cyst | entry into host | 15/496 | 151/18723 | 1.19e-05 | 7.97e-04 | 15 |
GO:005212622 | Liver | Cyst | movement in host environment | 16/496 | 175/18723 | 1.76e-05 | 1.12e-03 | 16 |
GO:003410922 | Liver | Cyst | homotypic cell-cell adhesion | 11/496 | 90/18723 | 2.54e-05 | 1.56e-03 | 11 |
GO:005170132 | Liver | Cyst | biological process involved in interaction with host | 17/496 | 203/18723 | 3.04e-05 | 1.78e-03 | 17 |
GO:00716216 | Liver | Cyst | granulocyte chemotaxis | 11/496 | 125/18723 | 4.95e-04 | 1.48e-02 | 11 |
GO:00421105 | Liver | Cyst | T cell activation | 26/496 | 487/18723 | 6.07e-04 | 1.73e-02 | 26 |
GO:007063311 | Liver | Cyst | transepithelial transport | 5/496 | 31/18723 | 1.23e-03 | 3.05e-02 | 5 |
GO:00305936 | Liver | Cyst | neutrophil chemotaxis | 9/496 | 103/18723 | 1.66e-03 | 3.78e-02 | 9 |
GO:00975306 | Liver | Cyst | granulocyte migration | 11/496 | 148/18723 | 1.98e-03 | 4.15e-02 | 11 |
GO:00975296 | Liver | Cyst | myeloid leukocyte migration | 14/496 | 220/18723 | 2.28e-03 | 4.59e-02 | 14 |
GO:00160328 | Lung | IAC | viral process | 94/2061 | 415/18723 | 5.11e-12 | 4.27e-09 | 94 |
GO:00190588 | Lung | IAC | viral life cycle | 77/2061 | 317/18723 | 1.23e-11 | 4.83e-09 | 77 |
GO:00521268 | Lung | IAC | movement in host environment | 48/2061 | 175/18723 | 1.30e-09 | 2.21e-07 | 48 |
GO:00315327 | Lung | IAC | actin cytoskeleton reorganization | 35/2061 | 107/18723 | 1.44e-09 | 2.38e-07 | 35 |
GO:00517018 | Lung | IAC | biological process involved in interaction with host | 52/2061 | 203/18723 | 3.74e-09 | 5.84e-07 | 52 |
GO:00467188 | Lung | IAC | viral entry into host cell | 41/2061 | 144/18723 | 6.27e-09 | 9.08e-07 | 41 |
GO:00444098 | Lung | IAC | entry into host | 42/2061 | 151/18723 | 8.80e-09 | 1.19e-06 | 42 |
GO:00444038 | Lung | IAC | biological process involved in symbiotic interaction | 63/2061 | 290/18723 | 8.57e-08 | 8.34e-06 | 63 |
GO:00452168 | Lung | IAC | cell-cell junction organization | 43/2061 | 200/18723 | 1.21e-05 | 3.64e-04 | 43 |
GO:0042692 | Lung | IAC | muscle cell differentiation | 65/2061 | 384/18723 | 2.75e-04 | 4.54e-03 | 65 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0541618 | Breast | Precancer | Viral myocarditis | 14/684 | 60/8465 | 2.32e-04 | 1.98e-03 | 1.52e-03 | 14 |
hsa0541619 | Breast | Precancer | Viral myocarditis | 14/684 | 60/8465 | 2.32e-04 | 1.98e-03 | 1.52e-03 | 14 |
hsa0541623 | Breast | IDC | Viral myocarditis | 18/867 | 60/8465 | 1.85e-05 | 2.01e-04 | 1.50e-04 | 18 |
hsa0541633 | Breast | IDC | Viral myocarditis | 18/867 | 60/8465 | 1.85e-05 | 2.01e-04 | 1.50e-04 | 18 |
hsa0541642 | Breast | DCIS | Viral myocarditis | 19/846 | 60/8465 | 3.12e-06 | 4.20e-05 | 3.09e-05 | 19 |
hsa0541652 | Breast | DCIS | Viral myocarditis | 19/846 | 60/8465 | 3.12e-06 | 4.20e-05 | 3.09e-05 | 19 |
hsa0541626 | Endometrium | EEC | Viral myocarditis | 28/1237 | 60/8465 | 2.81e-09 | 5.77e-08 | 4.30e-08 | 28 |
hsa0541635 | Endometrium | EEC | Viral myocarditis | 28/1237 | 60/8465 | 2.81e-09 | 5.77e-08 | 4.30e-08 | 28 |
hsa0541630 | Esophagus | ESCC | Viral myocarditis | 41/4205 | 60/8465 | 2.59e-03 | 7.05e-03 | 3.61e-03 | 41 |
hsa05416114 | Esophagus | ESCC | Viral myocarditis | 41/4205 | 60/8465 | 2.59e-03 | 7.05e-03 | 3.61e-03 | 41 |
hsa0541614 | Liver | Cirrhotic | Viral myocarditis | 28/2530 | 60/8465 | 4.38e-03 | 1.68e-02 | 1.03e-02 | 28 |
hsa0541615 | Liver | Cirrhotic | Viral myocarditis | 28/2530 | 60/8465 | 4.38e-03 | 1.68e-02 | 1.03e-02 | 28 |
hsa0541621 | Liver | Cyst | Viral myocarditis | 9/339 | 60/8465 | 5.79e-04 | 6.94e-03 | 5.73e-03 | 9 |
hsa0541631 | Liver | Cyst | Viral myocarditis | 9/339 | 60/8465 | 5.79e-04 | 6.94e-03 | 5.73e-03 | 9 |
hsa0541616 | Lung | IAC | Viral myocarditis | 21/1053 | 60/8465 | 5.30e-06 | 1.57e-04 | 1.04e-04 | 21 |
hsa0541617 | Lung | IAC | Viral myocarditis | 21/1053 | 60/8465 | 5.30e-06 | 1.57e-04 | 1.04e-04 | 21 |
hsa0541622 | Lung | AIS | Viral myocarditis | 19/961 | 60/8465 | 2.01e-05 | 4.08e-04 | 2.61e-04 | 19 |
hsa0541632 | Lung | AIS | Viral myocarditis | 19/961 | 60/8465 | 2.01e-05 | 4.08e-04 | 2.61e-04 | 19 |
hsa0541661 | Lung | MIAC | Viral myocarditis | 15/507 | 60/8465 | 1.61e-06 | 9.39e-05 | 6.79e-05 | 15 |
hsa0541671 | Lung | MIAC | Viral myocarditis | 15/507 | 60/8465 | 1.61e-06 | 9.39e-05 | 6.79e-05 | 15 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CXADR | SNV | Missense_Mutation | rs760582039 | c.734G>A | p.Gly245Glu | p.G245E | P78310 | protein_coding | deleterious(0.01) | probably_damaging(0.974) | TCGA-OL-A5RZ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
CXADR | SNV | Missense_Mutation | novel | c.400N>T | p.His134Tyr | p.H134Y | P78310 | protein_coding | tolerated(0.18) | benign(0.018) | TCGA-VS-A94Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CXADR | SNV | Missense_Mutation | c.923C>T | p.Ser308Phe | p.S308F | P78310 | protein_coding | deleterious(0.04) | benign(0.171) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
CXADR | SNV | Missense_Mutation | rs778453029 | c.791G>A | p.Arg264His | p.R264H | P78310 | protein_coding | tolerated(0.18) | benign(0.043) | TCGA-D5-6540-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
CXADR | SNV | Missense_Mutation | rs374465561 | c.131N>T | p.Thr44Met | p.T44M | P78310 | protein_coding | deleterious(0.02) | possibly_damaging(0.519) | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CXADR | SNV | Missense_Mutation | c.289N>T | p.Asp97Tyr | p.D97Y | P78310 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CXADR | SNV | Missense_Mutation | c.1091N>C | p.Ile364Thr | p.I364T | P78310 | protein_coding | deleterious(0) | possibly_damaging(0.82) | TCGA-F5-6464-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
CXADR | SNV | Missense_Mutation | rs772476067 | c.388A>G | p.Asn130Asp | p.N130D | P78310 | protein_coding | deleterious(0.01) | benign(0.203) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CXADR | deletion | Frame_Shift_Del | c.597delN | p.Asn201MetfsTer27 | p.N201Mfs*27 | P78310 | protein_coding | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |||
CXADR | SNV | Missense_Mutation | rs368675196 | c.323N>T | p.Thr108Met | p.T108M | P78310 | protein_coding | tolerated(0.1) | benign(0.44) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |